These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 19702828)

  • 1. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
    Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
    Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-183 potentially inhibits NF-κB1 expression by directly targeting its 3'-untranslated region.
    Sha F; Wu S; Zhang H; Guo X
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):991-6. PubMed ID: 25274328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway.
    Liu N; Sun Q; Chen J; Li J; Zeng Y; Zhai S; Li P; Wang B; Wang X
    Oncol Rep; 2012 Sep; 28(3):961-8. PubMed ID: 22825752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-145 inhibits breast cancer cell growth through RTKN.
    Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
    Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
    Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
    Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
    Wynendaele J; Böhnke A; Leucci E; Nielsen SJ; Lambertz I; Hammer S; Sbrzesny N; Kubitza D; Wolf A; Gradhand E; Balschun K; Braicu I; Sehouli J; Darb-Esfahani S; Denkert C; Thomssen C; Hauptmann S; Lund A; Marine JC; Bartel F
    Cancer Res; 2010 Dec; 70(23):9641-9. PubMed ID: 21084273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Leivonen SK; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale AL; Saviranta P; Perälä M; Kallioniemi O
    Oncogene; 2009 Nov; 28(44):3926-36. PubMed ID: 19684618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
    Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
    Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B
    Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
    Li J; Liang SH; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
    Liu T; Tang H; Lang Y; Liu M; Li X
    Cancer Lett; 2009 Jan; 273(2):233-42. PubMed ID: 18789835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
    Tsang WP; Ng EK; Ng SS; Jin H; Yu J; Sung JJ; Kwok TT
    Carcinogenesis; 2010 Mar; 31(3):350-8. PubMed ID: 19926638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
    Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
    Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
    Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.